199 related articles for article (PubMed ID: 17484228)
41. Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva.
Haidopoulos D; Diakomanolis E; Rodolakis A; Vlachos G; Elsheikh A; Michalas S
Arch Gynecol Obstet; 2004 Dec; 270(4):240-3. PubMed ID: 14648072
[TBL] [Abstract][Full Text] [Related]
42. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
[TBL] [Abstract][Full Text] [Related]
43. FDA approval of imiquimod cream in treatment of STD warts.
AIDS Patient Care STDS; 1997 Oct; 11(5):377-8. PubMed ID: 11361830
[No Abstract] [Full Text] [Related]
44. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
Schaen L; Mercurio MG
Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy.
Saiag P; Bourgault-Villada I; Pavlovic M; Roudier-Pujol C
AIDS; 2002 Jul; 16(10):1438-40. PubMed ID: 12131230
[No Abstract] [Full Text] [Related]
46. Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry.
Gutzmer R; Kaspari M; Vogelbruch M; Kiehl P; Kapp A; Werfel T; Brodersen JP
Br J Dermatol; 2002 Jul; 147(1):160-5. PubMed ID: 12100202
[TBL] [Abstract][Full Text] [Related]
47. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
49. Topical imiquimod therapy for external anogenital warts in pregnant women.
Audisio T; Roca FC; Piatti C
Int J Gynaecol Obstet; 2008 Mar; 100(3):275-6. PubMed ID: 18035356
[No Abstract] [Full Text] [Related]
50. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
Yan J; Chen SL; Wang HN; Wu TX
Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
[TBL] [Abstract][Full Text] [Related]
51. Induction of vitiligo after imiquimod treatment of condylomata acuminata.
Li W; Xin H; Ge L; Song H; Cao W
BMC Infect Dis; 2014 Jun; 14():329. PubMed ID: 24928346
[TBL] [Abstract][Full Text] [Related]
52. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.
Rosenblatt A; de Campos Guidi HG
Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837
[TBL] [Abstract][Full Text] [Related]
53. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
Arican O; Guneri F; Bilgic K; Karaoglu A
J Dermatol; 2004 Aug; 31(8):627-31. PubMed ID: 15492435
[TBL] [Abstract][Full Text] [Related]
54. [Extensive condyloma acuminata of the penis successfully treated with 5% imiquimod cream].
Cortés JR; Arratia J; Martínez R; Gómez L
Actas Urol Esp; 2007 Mar; 31(3):276-8. PubMed ID: 17658157
[TBL] [Abstract][Full Text] [Related]
55. 5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.
Cusini M; Salmaso F; Zerboni R; Carminati G; Vernaci C; Franchi C; Locatelli A; Alessi E
Int J STD AIDS; 2004 Jan; 15(1):17-20. PubMed ID: 14769165
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of imiquimod 5% cream for treatment of perianal warts in a 28-month-old child.
Masuko T; Fuchigami T; Inadomi T; Inamo Y; Hashimoto K
Pediatr Int; 2011 Oct; 53(5):764-766. PubMed ID: 21955010
[No Abstract] [Full Text] [Related]
57. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742
[TBL] [Abstract][Full Text] [Related]
58. Successful treatment of extensive condyloma acuminata of the inguinal area and thigh with topical imiquimod cream.
Weinberg JM; Stewart A; Stern JO
Acta Derm Venereol; 2001; 81(1):76-7. PubMed ID: 11411935
[No Abstract] [Full Text] [Related]
59. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
60. [Imiquimod cream. A cream to use with precaution].
Taeron C
Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
